Literature DB >> 32856840

Comment for the "EpCAM-based Flow Cytometric Detection of Circulating Tumor Cells in Gallbladder Carcinoma Cases".

Gokce Gullu Amuran1.   

Abstract

Entities:  

Keywords:  CD61; CTC; EasySep; Hybrid mesanchimal

Mesh：

Substances：

Year:  2020        PMID： 32856840      PMCID： PMC7771949          DOI： 10.31557/APJCP.2020.21.8.2179

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN： 1513-7368


× No keyword cloud information.
  10 in total

1.  Circulating Tumor Cells with Stemness and Epithelial-to-Mesenchymal Transition Features Are Chemoresistant and Predictive of Poor Outcome in Metastatic Breast Cancer.

Authors:  Maria A Papadaki; Giannis Stoupis; Panayiotis A Theodoropoulos; Dimitris Mavroudis; Vassilis Georgoulias; Sofia Agelaki
Journal:  Mol Cancer Ther       Date:  2018-11-06       Impact factor: 6.261

2.  Meta-analysis of the prognostic value of circulating tumor cells in breast cancer.

Authors:  Liling Zhang; Sabine Riethdorf; Gang Wu; Tao Wang; Kunyu Yang; Gang Peng; Junli Liu; Klaus Pantel
Journal:  Clin Cancer Res       Date:  2012-08-20       Impact factor: 12.531

3.  Transition states that allow cancer to spread.

Authors:  Erik W Thompson; Shivashankar H Nagaraj
Journal:  Nature       Date:  2018-04       Impact factor: 49.962

4.  Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition.

Authors:  Min Yu; Aditya Bardia; Ben S Wittner; Shannon L Stott; Malgorzata E Smas; David T Ting; Steven J Isakoff; Jordan C Ciciliano; Marissa N Wells; Ajay M Shah; Kyle F Concannon; Maria C Donaldson; Lecia V Sequist; Elena Brachtel; Dennis Sgroi; Jose Baselga; Sridhar Ramaswamy; Mehmet Toner; Daniel A Haber; Shyamala Maheswaran
Journal:  Science       Date:  2013-02-01       Impact factor: 47.728

5.  Response Assessment With Molecular Characterization of Circulating Tumor Cells and Plasma MicroRNA Profiling in Patients With Locally Advanced Breast Cancer During Neoadjuvant Chemotherapy.

Authors:  Mustafa Akkiprik; Sinan Koca; M Ümit Uğurlu; Rüçhan Ekren; İrem Peker Eyüboğlu; Özkan Alan; Can Erzik; Gökçe Güllü Amuran; Tuğba Akın Telli; M Bahadır Güllüoğlu; Uğur Sezerman; Perran Fulden Yumuk
Journal:  Clin Breast Cancer       Date:  2020-02-26       Impact factor: 3.225

Review 6.  Circulating tumor cells as promising novel biomarkers in solid cancers.

Authors:  Evi S Lianidou; Areti Strati; Athina Markou
Journal:  Crit Rev Clin Lab Sci       Date:  2014-03-19       Impact factor: 6.250

7.  Identification of the tumour transition states occurring during EMT.

Authors:  Ievgenia Pastushenko; Audrey Brisebarre; Alejandro Sifrim; Marco Fioramonti; Tatiana Revenco; Soufiane Boumahdi; Alexandra Van Keymeulen; Daniel Brown; Virginie Moers; Sophie Lemaire; Sarah De Clercq; Esmeralda Minguijón; Cédric Balsat; Youri Sokolow; Christine Dubois; Florian De Cock; Samuel Scozzaro; Federico Sopena; Angel Lanas; Nicky D'Haene; Isabelle Salmon; Jean-Christophe Marine; Thierry Voet; Panagiota A Sotiropoulou; Cédric Blanpain
Journal:  Nature       Date:  2018-04-18       Impact factor: 49.962

8.  EpCAM-based Flow Cytometric Detection of Circulating Tumor Cells in Gallbladder Carcinoma Cases

Authors:  Namrata Punit Awasthi; Swati Kumari; Azfar Neyaz; Sameer Gupta; Akash Agarwal; Ashish Singhal; Nuzhat Husain
Journal:  Asian Pac J Cancer Prev       Date:  2017-12-29

9.  Heterogeneity of Circulating Tumor Cells in Neoadjuvant Chemotherapy of Breast Cancer.

Authors:  Evgeniya V Kaigorodova; Olga E Savelieva; Liubov A Tashireva; Natalia A Tarabanovskaya; Elena I Simolina; Evgeny V Denisov; Elena M Slonimskaya; Evgeny L Choynzonov; Vladimir M Perelmuter
Journal:  Molecules       Date:  2018-03-22       Impact factor: 4.411

10.  Circulating tumor cells predict survival in early average-to-high risk breast cancer patients.

Authors:  Brigitte Rack; Christian Schindlbeck; Julia Jückstock; Ulrich Andergassen; Philip Hepp; Thomas Zwingers; Thomas W P Friedl; Ralf Lorenz; Hans Tesch; Peter A Fasching; Tanja Fehm; Andreas Schneeweiss; Werner Lichtenegger; Matthias W Beckmann; Klaus Friese; Klaus Pantel; Wolfgang Janni
Journal:  J Natl Cancer Inst       Date:  2014-05-15       Impact factor: 13.506
  10 in total
  1 in total

Review 1.  Antigallbladder Carcinoma Activity Analysis of a New Nanometer Drug Delivery System Based on Data Acquisition.

Authors:  Weidong Li; Zhiye Liu; Yuanyuan Liu; Lei Qian; Zhiyong Zhang; Lei Nie; Xiusheng Qu
Journal:  Contrast Media Mol Imaging       Date:  2022-07-06       Impact factor: 3.009
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.